Candidate gene analyses were notable for variations of potential interest in GRM7, which has been investigated in studies of schizophrenia, ADHD and autism.43, 44, 45 In exploratory genome-wide analyses, the findings of greatest statistical significance were in GRID2, a gene with evidence suggesting involvement in glutamate signaling. The gene discussed is GRID2; the disease is schizophrenia.